News

Brain cancer is often a devastating diagnosis, and scientists have been hunting for mechanisms that could explain the sources of brain tumours, with hopes to also find something that could prevent them.

Revolutionary three-in-one blood test could change treatment for advanced stages of disease, say scientists.

The approach is still in the early stages of testing, but initial results from four people look promising, with all showing some improvement 18 months after surgery.

Researchers have identified a subgroup of neurons in the mouse brain that, upon activation, immediately prompt binge-like eating.

Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. This deterioration is the primary risk factor for major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. Aging research has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and bioch...

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research.

Though research is ‘in its infancy’, drug olaparib could slow cancer growth for with inherited BRCA-related breast cancer, which tends to affect younger women

A team of researchers is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system. The technology allows scientists in the lab to 'light up' and then monitor a brain protein called alpha-synuclein that has been associated with Parkinson's.

Loxo Oncology is developing a so-called “tumor agnostic” drug that requires expensive genetic testing often not covered by insurance.

A single treatment giving life-long protection from severe allergies such as asthma could be made possible by recent immunology research.